ClinConnect ClinConnect Logo
Search / Trial NCT03613870

PermeaDerm® vs. Mepilex-Ag® in Promoting Healing of Partial-thickness Burn Wounds

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Jul 27, 2018

Trial Information

Current as of July 23, 2025

Withdrawn

Keywords

Permea Derm, Mepilex Ag, Partial Thickness Burn Wounds

ClinConnect Summary

In this prospective, randomized parallel study, the effectiveness of the wound dressings currently used at our institution for partial-thickness burn wounds will be compared: PermeaDerm®, and silver coated foam dressing Mepilex Ag®.This study is therefore considered a minimal risk study. Procedures related to research apart from randomization to one of the dressings, will include review of medical records, non-invasive wound and scar assessments and additional photographs.

60 patients with partial thickness burns meeting the inclusion criteria of the study will be enrolled to receive eithe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Superficial partial thickness burn injury due to flame burn, scald injury or contact burn that does not require excision and grafting
  • Total Body Surface Area burned (TBSA) total ≤30 %
  • Admission within 72 hours of burn injury
  • Non-infected wound as diagnosed by the attending physician upon admission
  • Treated as an outpatient or in an observational setting
  • Exclusion Criteria:
  • Patient younger than 6 months
  • Causes other than contact burn, flame or scald injuries (i.e., electrical, chemical or frostbite)
  • Admission time greater than 72 hours after the injury
  • Wounds noted to be infected at admission
  • Previous treatment efforts such as previous debridement, silver sulfadiazine ointment or other pseudo eschar-forming topical agents
  • Pregnancy/lactation

About The University Of Texas Medical Branch, Galveston

The University of Texas Medical Branch (UTMB) in Galveston is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. As a prominent sponsor of clinical trials, UTMB leverages its extensive resources, multidisciplinary expertise, and commitment to excellence to facilitate groundbreaking studies that address critical health challenges. With a focus on translating scientific discoveries into effective therapies, UTMB fosters collaboration among researchers, clinicians, and participants to enhance patient outcomes and contribute to the overall advancement of medical knowledge.

Locations

Galveston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Ludwik K Branski, MD

Principal Investigator

The University of Texas Medical Branch, Galveston

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials